Global Antiretroviral Therapy Market Insights, Forecast to 2025

Publisher Name :
Date: 06-Feb-2019
No. of pages: 113
Inquire Before Buying

The global Antiretroviral Therapy market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antiretroviral Therapy market based on company, product type, end user and key regions.

This report studies the global market size of Antiretroviral Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antiretroviral Therapy in these regions.

This research report categorizes the global Antiretroviral Therapy market by top players/brands, region, type and end user. This report also studies the global Antiretroviral Therapy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Gilead

- F. Hoffmann-La Roche

- ViiV Healthcare

- Boehringer Ingelheim

- Janssen Pharmaceuticals

- Mylan

- Abbvie

- Bionor Pharma

- Vertex Pharmaceuticals

Market size by Product

- NNRTIs

- NRTI

- Multiclass Combination Products

- Integrase Inhibitors

Market size by End User

- Hospital

- Clinic

- Other

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Antiretroviral Therapy market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Antiretroviral Therapy market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Antiretroviral Therapy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Antiretroviral Therapy submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Antiretroviral Therapy are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antiretroviral Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Antiretroviral Therapy Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Antiretroviral Therapy Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Antiretroviral Therapy Market Size Growth Rate by Product
1.4.2 NNRTIs
1.4.3 NRTI
1.4.4 Multiclass Combination Products
1.4.5 Integrase Inhibitors
1.5 Market by End User
1.5.1 Global Antiretroviral Therapy Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antiretroviral Therapy Market Size
2.1.1 Global Antiretroviral Therapy Revenue 2014-2025
2.1.2 Global Antiretroviral Therapy Sales 2014-2025
2.2 Antiretroviral Therapy Growth Rate by Regions
2.2.1 Global Antiretroviral Therapy Sales by Regions
2.2.2 Global Antiretroviral Therapy Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Antiretroviral Therapy Sales by Manufacturers
3.1.1 Antiretroviral Therapy Sales by Manufacturers
3.1.2 Antiretroviral Therapy Sales Market Share by Manufacturers
3.1.3 Global Antiretroviral Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Antiretroviral Therapy Revenue by Manufacturers
3.2.1 Antiretroviral Therapy Revenue by Manufacturers (2014-2019)
3.2.2 Antiretroviral Therapy Revenue Share by Manufacturers (2014-2019)
3.3 Antiretroviral Therapy Price by Manufacturers
3.4 Antiretroviral Therapy Manufacturing Base Distribution, Product Types
3.4.1 Antiretroviral Therapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antiretroviral Therapy Product Type
3.4.3 Date of International Manufacturers Enter into Antiretroviral Therapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Antiretroviral Therapy Sales by Product
4.2 Global Antiretroviral Therapy Revenue by Product
4.3 Antiretroviral Therapy Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Antiretroviral Therapy Breakdown Data by End User
6 North America
6.1 North America Antiretroviral Therapy by Countries
6.1.1 North America Antiretroviral Therapy Sales by Countries
6.1.2 North America Antiretroviral Therapy Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Antiretroviral Therapy by Product
6.3 North America Antiretroviral Therapy by End User
7 Europe
7.1 Europe Antiretroviral Therapy by Countries
7.1.1 Europe Antiretroviral Therapy Sales by Countries
7.1.2 Europe Antiretroviral Therapy Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antiretroviral Therapy by Product
7.3 Europe Antiretroviral Therapy by End User
8 Asia Pacific
8.1 Asia Pacific Antiretroviral Therapy by Countries
8.1.1 Asia Pacific Antiretroviral Therapy Sales by Countries
8.1.2 Asia Pacific Antiretroviral Therapy Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Antiretroviral Therapy by Product
8.3 Asia Pacific Antiretroviral Therapy by End User
9 Central & South America
9.1 Central & South America Antiretroviral Therapy by Countries
9.1.1 Central & South America Antiretroviral Therapy Sales by Countries
9.1.2 Central & South America Antiretroviral Therapy Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Antiretroviral Therapy by Product
9.3 Central & South America Antiretroviral Therapy by End User
10 Middle East and Africa
10.1 Middle East and Africa Antiretroviral Therapy by Countries
10.1.1 Middle East and Africa Antiretroviral Therapy Sales by Countries
10.1.2 Middle East and Africa Antiretroviral Therapy Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Antiretroviral Therapy by Product
10.3 Middle East and Africa Antiretroviral Therapy by End User
11 Company Profiles
11.1 Gilead
11.1.1 Gilead Company Details
11.1.2 Company Business Overview
11.1.3 Gilead Antiretroviral Therapy Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Gilead Antiretroviral Therapy Products Offered
11.1.5 Gilead Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 Company Business Overview
11.2.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales, Revenue and Gross Margin (2014-2019)
11.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Products Offered
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 ViiV Healthcare
11.3.1 ViiV Healthcare Company Details
11.3.2 Company Business Overview
11.3.3 ViiV Healthcare Antiretroviral Therapy Sales, Revenue and Gross Margin (2014-2019)
11.3.4 ViiV Healthcare Antiretroviral Therapy Products Offered
11.3.5 ViiV Healthcare Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Company Business Overview
11.4.3 Boehringer Ingelheim Antiretroviral Therapy Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Boehringer Ingelheim Antiretroviral Therapy Products Offered
11.4.5 Boehringer Ingelheim Recent Development
11.5 Janssen Pharmaceuticals
11.5.1 Janssen Pharmaceuticals Company Details
11.5.2 Company Business Overview
11.5.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Products Offered
11.5.5 Janssen Pharmaceuticals Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Company Business Overview
11.6.3 Mylan Antiretroviral Therapy Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Mylan Antiretroviral Therapy Products Offered
11.6.5 Mylan Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Company Business Overview
11.7.3 Abbvie Antiretroviral Therapy Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Abbvie Antiretroviral Therapy Products Offered
11.7.5 Abbvie Recent Development
11.8 Bionor Pharma
11.8.1 Bionor Pharma Company Details
11.8.2 Company Business Overview
11.8.3 Bionor Pharma Antiretroviral Therapy Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Bionor Pharma Antiretroviral Therapy Products Offered
11.8.5 Bionor Pharma Recent Development
11.9 Vertex Pharmaceuticals
11.9.1 Vertex Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Products Offered
11.9.5 Vertex Pharmaceuticals Recent Development
12 Future Forecast
12.1 Antiretroviral Therapy Market Forecast by Regions
12.1.1 Global Antiretroviral Therapy Sales Forecast by Regions 2019-2025
12.1.2 Global Antiretroviral Therapy Revenue Forecast by Regions 2019-2025
12.2 Antiretroviral Therapy Market Forecast by Product
12.2.1 Global Antiretroviral Therapy Sales Forecast by Product 2019-2025
12.2.2 Global Antiretroviral Therapy Revenue Forecast by Product 2019-2025
12.3 Antiretroviral Therapy Market Forecast by End User
12.4 North America Antiretroviral Therapy Forecast
12.5 Europe Antiretroviral Therapy Forecast
12.6 Asia Pacific Antiretroviral Therapy Forecast
12.7 Central & South America Antiretroviral Therapy Forecast
12.8 Middle East and Africa Antiretroviral Therapy Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antiretroviral Therapy Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Antiretroviral Therapy Product Picture
Table Antiretroviral Therapy Market Segments
Table Key Manufacturers Antiretroviral Therapy Covered
Table Global Antiretroviral Therapy Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Antiretroviral Therapy Sales Market Share by Product 2014-2025
Figure NNRTIs Product Picture
Table Major Manufacturers of NNRTIs
Figure NRTI Product Picture
Table Major Manufacturers of NRTI
Figure Multiclass Combination Products Product Picture
Table Major Manufacturers of Multiclass Combination Products
Figure Integrase Inhibitors Product Picture
Table Major Manufacturers of Integrase Inhibitors
Table Global Antiretroviral Therapy Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital
Figure Clinic
Figure Other
Figure Antiretroviral Therapy Report Years Considered
Figure Global Antiretroviral Therapy Market Size 2014-2025 (Million US$)
Figure Global Antiretroviral Therapy Sales 2014-2025 (K Units)
Table Global Antiretroviral Therapy Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Antiretroviral Therapy Sales by Regions 2014-2019 (K Units)
Table Global Antiretroviral Therapy Sales Market Share by Regions 2014-2019
Figure Global Antiretroviral Therapy Sales Market Share by Regions 2014-2019
Figure 2018 Global Antiretroviral Therapy Sales Market Share by Regions
Table Global Antiretroviral Therapy Revenue by Regions 2014-2019 (Million US$)
Table Global Antiretroviral Therapy Revenue Market Share by Regions 2014-2019
Figure Global Antiretroviral Therapy Revenue Market Share by Regions 2014-2019
Figure 2018 Global Antiretroviral Therapy Revenue Market Share by Regions
Table Global Antiretroviral Therapy Sales by Manufacturers (2014-2019) (K Units)
Table Global Antiretroviral Therapy Sales Share by Manufacturers (2014-2019)
Figure Global Antiretroviral Therapy Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Antiretroviral Therapy Revenue by Manufacturers (2014-2019) (Million USD)
Table Antiretroviral Therapy Revenue Share by Manufacturers (2014-2019)
Figure Antiretroviral Therapy Value Share by Manufacturers in 2018
Table Key Manufacturers Antiretroviral Therapy Price (2014-2019) (USD/Unit)
Table Antiretroviral Therapy Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Antiretroviral Therapy Product Type
Table Date of International Manufacturers Enter into Antiretroviral Therapy Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Antiretroviral Therapy Sales by Product (2014-2019) (K Units)
Table Global Antiretroviral Therapy Sales Share by Product (2014-2019)
Figure Global Antiretroviral Therapy Sales Market Share by Product (2014-2019)
Figure Global Antiretroviral Therapy Sales Market Share by Product in 2018
Table Global Antiretroviral Therapy Revenue by Product (2014-2019) (Million US$)
Table Global Antiretroviral Therapy Revenue Share by Product (2014-2019)
Figure Global Antiretroviral Therapy Revenue Market Share by Product (2014-2019)
Figure Global Antiretroviral Therapy Revenue Market Share by Product in 2018
Table Antiretroviral Therapy Price by Product 2014-2019 (USD/Unit)
Table Global Antiretroviral Therapy Sales by End User (2014-2019) (K Units)
Table Global Antiretroviral Therapy Sales Share by End User (2014-2019)
Figure Global Sales Antiretroviral Therapy Market Share by End User (2014-2019)
Figure Global Sales Antiretroviral Therapy Market Share by End User in 2018
Figure North America Antiretroviral Therapy Sales Growth Rate 2014-2019 (K Units)
Figure North America Antiretroviral Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table North America Antiretroviral Therapy Sales by Countries (2014-2019) (K Units)
Table North America Antiretroviral Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 North America Antiretroviral Therapy Sales Market Share by Countries
Table North America Antiretroviral Therapy Revenue by Countries (2014-2019) (Million US$)
Table North America Antiretroviral Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Antiretroviral Therapy Revenue Market Share by Countries
Figure United States Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure United States Antiretroviral Therapy Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Canada Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table North America Antiretroviral Therapy Sales by Product (2014-2019) (K Units)
Table North America Antiretroviral Therapy Sales Market Share by Product (2014-2019)
Figure 2018 North America Antiretroviral Therapy Market Share by Product
Table North America Antiretroviral Therapy Sales by End User (2014-2019) (K Units)
Table North America Antiretroviral Therapy Sales Market Share by End User (2014-2019)
Figure 2018 North America Antiretroviral Therapy Market Share by End User
Figure Europe Antiretroviral Therapy Sales Growth Rate 2014-2019 (K Units)
Figure Europe Antiretroviral Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Antiretroviral Therapy Sales by Countries (2014-2019) (K Units)
Table Europe Antiretroviral Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Antiretroviral Therapy Sales Market Share by Countries
Table Europe Antiretroviral Therapy Revenue by Countries (2014-2019) (Million US$)
Table Europe Antiretroviral Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Antiretroviral Therapy Revenue Market Share by Countries
Figure Germany Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Germany Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure France Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure France Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure UK Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Italy Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Russia Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Antiretroviral Therapy Sales by Product (2014-2019) (K Units)
Table Europe Antiretroviral Therapy Sales Market Share by Product (2014-2019)
Figure 2018 Europe Antiretroviral Therapy Market Share by Product
Table Europe Antiretroviral Therapy Sales by End User (2014-2019) (K Units)
Table Europe Antiretroviral Therapy Sales Market Share by End User (2014-2019)
Figure 2018 Europe Antiretroviral Therapy Market Share by End User
Figure Asia Pacific Antiretroviral Therapy Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Antiretroviral Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Antiretroviral Therapy Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Antiretroviral Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antiretroviral Therapy Sales Market Share by Countries
Table Asia Pacific Antiretroviral Therapy Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Antiretroviral Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antiretroviral Therapy Revenue Market Share by Countries
Figure China Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure China Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Japan Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Korea Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure India Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure India Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Australia Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Antiretroviral Therapy Sales by Product (2014-2019) (K Units)
Table Asia Pacific Antiretroviral Therapy Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Antiretroviral Therapy Market Share by Product
Table Asia Pacific Antiretroviral Therapy Sales by End User (2014-2019) (K Units)
Table Asia Pacific Antiretroviral Therapy Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Antiretroviral Therapy Market Share by End User
Figure Central & South America Antiretroviral Therapy Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Antiretroviral Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Antiretroviral Therapy Sales by Countries (2014-2019) (K Units)
Table Central & South America Antiretroviral Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antiretroviral Therapy Sales Market Share by Countries
Table Central & South America Antiretroviral Therapy Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Antiretroviral Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antiretroviral Therapy Revenue Market Share by Countries
Figure Brazil Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Antiretroviral Therapy Sales by Product (2014-2019) (K Units)
Table Central & South America Antiretroviral Therapy Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Antiretroviral Therapy Market Share by Product
Table Central & South America Antiretroviral Therapy Sales by End User (2014-2019) (K Units)
Table Central & South America Antiretroviral Therapy Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Antiretroviral Therapy Market Share by End User
Figure Middle East and Africa Antiretroviral Therapy Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Antiretroviral Therapy Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Antiretroviral Therapy Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Antiretroviral Therapy Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antiretroviral Therapy Sales Market Share by Countries
Table Middle East and Africa Antiretroviral Therapy Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Antiretroviral Therapy Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antiretroviral Therapy Revenue Market Share by Countries
Figure GCC Countries Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Antiretroviral Therapy Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Antiretroviral Therapy Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Antiretroviral Therapy Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Antiretroviral Therapy Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Antiretroviral Therapy Market Share by Product
Table Middle East and Africa Antiretroviral Therapy Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Antiretroviral Therapy Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Antiretroviral Therapy Market Share by End User
Table Gilead Company Details
Table Gilead Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Gilead Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table ViiV Healthcare Company Details
Table ViiV Healthcare Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table ViiV Healthcare Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Janssen Pharmaceuticals Company Details
Table Janssen Pharmaceuticals Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Janssen Pharmaceuticals Recent Development
Table Mylan Company Details
Table Mylan Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mylan Recent Development
Table Abbvie Company Details
Table Abbvie Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbvie Recent Development
Table Bionor Pharma Company Details
Table Bionor Pharma Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bionor Pharma Recent Development
Table Vertex Pharmaceuticals Company Details
Table Vertex Pharmaceuticals Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Vertex Pharmaceuticals Recent Development
Table Global Antiretroviral Therapy Sales Forecast by Regions 2019-2025 (K Units)
Table Global Antiretroviral Therapy Sales Market Share Forecast by Regions 2019-2025
Table Global Antiretroviral Therapy Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Antiretroviral Therapy Revenue Market Share Forecast by Regions 2019-2025
Table Global Antiretroviral Therapy Sales Forecast by Product 2019-2025 (K Units)
Table Global Antiretroviral Therapy Sales Market Share Forecast by Product 2019-2025
Table Global Antiretroviral Therapy Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Antiretroviral Therapy Revenue Market Share Forecast by Product 2019-2025
Table Global Antiretroviral Therapy Sales Forecast by End User 2019-2025 (K Units)
Table Global Antiretroviral Therapy Sales Market Share Forecast by End User 2019-2025
Figure North America Antiretroviral Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Antiretroviral Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Antiretroviral Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Antiretroviral Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Antiretroviral Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Antiretroviral Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Antiretroviral Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Antiretroviral Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Antiretroviral Therapy Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Antiretroviral Therapy Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Antiretroviral Therapy Value Chain
Table Antiretroviral Therapy Customers List
Table Antiretroviral Therapy Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Antiretroviral Therapy Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 04-Apr-2020        Price: US 3000 Onwards        Pages: 143
    Antiretroviral Therapy Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Antiretroviral Therapy industry with a focus on the Chinese market. The report provides key statistics on the market status of the Antiretroviral Therapy manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chine......
  • Global Antiretroviral Therapy Market Research Report 2020
    Published: 02-Mar-2020        Price: US 2900 Onwards        Pages: 90
    This report focuses on Antiretroviral Therapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antiretroviral Therapy market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer c......
  • 2020-2025 Global and Regional Antiretroviral Therapy Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report
    Published: 05-Feb-2020        Price: US 3500 Onwards        Pages: 142
    HNY Research projects that the Antiretroviral Therapy market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025. By Market Players: By Application Hospital, Clinic, Other By Type NNRTIs, NRTI, Multiclass Combination Products, Integrase Inhibitors By Gilead F. Hoffmann-La Roche, ViiV Healthcare,......
  • Global (United States, European Union and China) Antiretroviral Therapy Market Research Report 2019-2025
    Published: 15-Apr-2019        Price: US 3280 Onwards        Pages: 110
    In 2019, the market size of Antiretroviral Therapy is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antiretroviral Therapy. This report studies the global market ......
  • Global Antiretroviral Therapy Market Insights, Forecast to 2025
    Published: 06-Feb-2019        Price: US 4900 Onwards        Pages: 113
    The global Antiretroviral Therapy market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antiretroviral Therapy market based on company, product type, end user and key regions. This report studies the global market size of Antiretroviral Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Mi......
  • HIV-associated Lipodystrophy - Epidemiology Forecast to 2028
    Published: 15-Jan-2019        Price: US 3250 Onwards        Pages: 50
    DelveInsight's "HIV-associated Lipodystrophy - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the HIV-associated Lipodystrophy epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2028 HIV-associated Lipodystrophy Epidemiology......
  • HIV-associated Lipodystrophy - Market Insight, Epidemiology and Market Forecast - 2028
    Published: 15-Jan-2019        Price: US 6250 Onwards        Pages: 100
    DelveInsight's "HIV-associated Lipodystrophy - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the HIV-associated Lipodystrophy epidemiology and market outlook for the 7MM. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2028 HIV-associated Lipodystrophy Understanding and Treatment Algorithm The market re......
  • Global and Chinese Antiretroviral Therapy Industry, 2018 Market Research Report
    Published: 22-Nov-2018        Price: US 3000 Onwards        Pages: 137
    The 'Global and Chinese Antiretroviral Therapy Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Antiretroviral Therapy industry with a focus on the Chinese market. The report provides key statistics on the market status of the Antiretroviral Therapy manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industr......
  • Diagnostics and Therapeutics for HIV: Global Markets
    Published: 24-Oct-2018        Price: US 5500 Onwards        Pages: 184
    Report Scope: This report organizes information from diverse sources into sections, including an overview, industry structure, diagnostic test type, treatment by drug categories, leading drug profiles and historic drug sales, regulations, reimbursements and patents. The scope of this report includes an overview of the global market scenario for diagnosis and treatments of HIV, with base year data from 2017, estimations for 2018 and forecasts for 2023 using projections of CAGR duri......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs